Login / Signup

Neoadjuvant inetetamab and pertuzumab with taxanes and carboplatin (TCbIP) In locally advanced HER2-positive breast cancer: a prospective cohort study with propensity-matched analysis.

Mingxia JiangYue ChaiJiaxuan LiuMaiyue HeYipeng WangXue YangZeyu XingMengqi ZhangShihan ZhouFei MaJiayu WangPeng YuanBinghe XuQiao Li
Published in: BMC cancer (2024)
NCT05749016 (registration date: Nov 01, 2021).
Keyphrases
  • locally advanced
  • positive breast cancer
  • rectal cancer
  • phase ii study
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • lymph node
  • epidermal growth factor receptor
  • tyrosine kinase
  • open label